Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03521245 |
| Title | Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer |
| Recruitment | Unknown status |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Omicsway Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| OmicsWay Corp. | Walnut | California | 91789 | United States | Details | |
| Republican Oncological Dispensary of the Ministry of Healthcare of Karelia Republic | Petrozavodsk | Karelia Republic | 185007 | Russian Federation | Details | |
| Vitamed LLC | Moscow | 121309 | Russian Federation | Details | ||
| "Oncobox" Ltd. | Moscow | 143026 | Russian Federation | Details |